Work

Phase I Trial of Targeted EGFR or ALK Therapy with Ipilimumab in Metastatic NSCLC with Long-Term Follow-Up

Year: 2019

Type: article

Study design: Clinical Trial

Source: Targeted Oncology

DOI: 10.1007/s11523-019-00658-0

Authors: Anna W. Chalmers, Shiven Patel, Ken Boucher, Laura Cannon, Michelle Esplin, Julie Luckart, Natalie Graves, Terry Van Duren, Wallace Akerley

Institutions: University of Utah, Huntsman Cancer Institute, Utah Cancer Specialists, Dana-Farber Cancer Institute

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Bristol-Myers Squibb

OpenAlex ID: W2963997426

FWCI: 5.054

Cites: 23

Cited by: 50

Related to: 10